Decentralized trials

One is very common, the other is rarely granted. Learn the key differences between waiver of consent & waiver of written consent for clinical trials

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

For successful decentralized clinical trials, researchers must encourage patient engagement. Learn 5 steps that modern companies are taking for better outcomes.

Castor is shifting the research paradigm for eCRF in clinical trials, transitioning from old, inefficient processes to a comprehensive CDMS & DCT platform.

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

Leaders from Castor discuss what changes we can expect in clinical research, technology, and data through the lens of three key pillars

Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may…

Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications. This article explores current regulations for various classes of medical devices and how this will impact the need for participants to visit research sites throughout the trial.

The Castor team is thrilled to see an increasing emphasis on diversity of race, gender, and even geography amongst clinical trial participants. Critically, experts call for not just increased diversity on a statistical basis, but that the studied population is representative of the distribution of the disease.